Long-term survival after tricuspid valvulectomy for infective endocarditis.
DOI:
https://doi.org/10.37615/retic.v7n2a8Keywords:
endocarditis, tricuspid valve., heart valvesAbstract
Infective endocarditis affecting the right cavities represents approximately 5% of the total of endocarditis cases. We present a case with a history of three-valve infective endocarditis, treated with biological aortic prosthesis, mitral valve repair, and tricuspid valvulectomy. Cardiac imaging study performed twenty years after surgery showed a severely dilated right ventricle with normal systolic function. The right ventricle can adapt to volume overload for a long period of time; however, the implantation of a tricuspid prosthesis is needed to prevent long term right ventricular dysfunction
Downloads
Metrics
References
Musci M, Siniawski H, Pasic M, Grauhan O, Weng Y, Meyer R, et al. Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart : 20-year single center experience. Eur J Cardiothorac Surg. 2007, Jul;32(1):118-25. doi: https://doi.org/10.1016/j.ejcts.2007.02.034 DOI: https://doi.org/10.1016/j.ejcts.2007.02.034
Baddour LM, Freeman WK, Suri RM, Wilson YWR. Capitulo 73 - Infecciones cardiovasculares. Eleventh E. Braunwald. Tratado de cardiología 11ed. Elsevier España; 2020. p. 1483–509.
Rozo-Ortiz EJ, Conta JA, Vargas-Rodríguez LJ, Pinzón-Olmos MA. Endocarditis tricúspide con embolia pulmonar séptica : una afección infrecuente. Med Int Méx [Internet]. 2022;38(3):695–700. doi: https://doi.org/10.24245/mim.v38i3.4176 DOI: https://doi.org/10.24245/mim.v38i3.4176
Nishimura RA, Otto CM, Bonow RO, Iii JPE, Fleisher LA, Jneid H, et al. 2017 AHA / ACC Focused Update of the 2014 AHA / ACC Guideline for the Management of Patients With Valvular Heart Disease A Report of the American College of Cardiology / American Heart Association Task Force on Clinical Practice Guidelines. Circulation 2017;135:e1159–e1195. doi: https://doi.org/10.1161/CIR.0000000000000503 DOI: https://doi.org/10.1161/CIR.0000000000000503
Rogers MP, Bitetzakis C, Patel A, Hooker RL. Heart failure presentation thirty years after tricuspid valvectomy for infective endocarditis. JTCVS Tech. 2022 Apr; 12: 65–67. doi: https://doi.org/10.1016/j.xjtc.2022.01.017 DOI: https://doi.org/10.1016/j.xjtc.2022.01.017
Luc JGY, Choi J, Kodia K, Weber MP, Horan DP, Maynes EJ, et al. Valvectomy versus replacement for the surgical treatment of infective tricuspid valve endocarditis : a systematic review and meta-analysis. Annals of cardiothoracic surgery. 2019;8(6):610–20. doi: https://doi.org/10.21037/acs.2019.11.06 DOI: https://doi.org/10.21037/acs.2019.11.06
Pettersson GB, Coselli JS, Griffin B, Blackstone EH, Gordon SM, Lemaire SA, et al. The American Association for Thoracic Surgery ( AATS ) consensus guidelines : Surgical treatment of infective endocarditis : Executive summary J Thorac Cardiovasc Surg. 2017 Jun;153(6):1241-1258.e29. doi: https://doi.org/10.1016/j.jtcvs.2016.09.093 DOI: https://doi.org/10.1016/j.jtcvs.2016.09.093
Arbulu A, Holmes R, Asfaw I. Tricuspid valvulectomy without replacement. Twenty years’ experience. J Thorac Cardiovasc Surg. 1991;102(6):917–22. DOI: https://doi.org/10.1016/S0022-5223(19)33944-3
Sánchez-osella OF, De Carvalho MJ, De Matos JS, Bora Moleta D, Campos Vieira ML. ¿Se puede vivir sin la válvula tricúspide? Relato de dos casos de supervivencia de largo plazo. RETIC 2016;2:45–50. Disponible en https://doi.org/10.37615/retic.n2a11 DOI: https://doi.org/10.37615/retic.n2a11
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Juan Ramón Bravo Domínguez, Ximena Solar Sigala, José Alberto de Agustín Loeches, Ana Bustos García de Castro
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.